For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
A synthetic peptide corresponding to residues in the C-term of human p27(Kip1) was used as immunogen
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
A 40 µl trial size is available to purchase for this antibody.
Mouse: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our Abpromise guarantee covers the use of ab32034 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-Fr||Use at an assay dependent concentration.|
|IHC-P||Use at an assay dependent concentration.|
|ICC||Use at an assay dependent concentration.|
|IHC-FrFl||Use at an assay dependent concentration. PubMed: 23880266|
|WB||1/1000. Detects a band of approximately 27 kDa (predicted molecular weight: 22 kDa).|
|ICC/IF||1/100 - 1/250.|
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"